Recurrent Ovarian
Oncology
6 drugs in development·4 companies·1 clinical trial
Drug Pipeline by Phase
Phase 2(4)
Phase 1(1)
| Drug | Company |
|---|---|
| LDE225 | Novartis AG (NVS) |
Phase 4(1)
| Drug | Company |
|---|---|
| saruparib | ASTRAZENECA PLC (AZN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Recurrent Ovarian?
BioSniper tracks 6 drugs in development for Recurrent Ovarian across 4 companies.
How many clinical trials target Recurrent Ovarian?
There are 1 clinical trial targeting Recurrent Ovarian tracked by BioSniper.
Deep-dive into Recurrent Ovarian
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis